摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(3-(4-iodophenyl)quinolin-2-yl)ethan-1-amine | 1010857-69-8

中文名称
——
中文别名
——
英文名称
1-(3-(4-iodophenyl)quinolin-2-yl)ethan-1-amine
英文别名
——
1-(3-(4-iodophenyl)quinolin-2-yl)ethan-1-amine化学式
CAS
1010857-69-8
化学式
C17H15IN2
mdl
——
分子量
374.224
InChiKey
BWOKTHDSBAGATD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.53
  • 重原子数:
    20.0
  • 可旋转键数:
    2.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    38.91
  • 氢给体数:
    1.0
  • 氢受体数:
    2.0

反应信息

  • 作为反应物:
    描述:
    1-(3-(4-iodophenyl)quinolin-2-yl)ethan-1-amine乙基乙烯基砜 在 TEA 作用下, 以 甲醇 为溶剂, 生成
    参考文献:
    名称:
    Optimization of the heterocyclic core of the quinazolinone-derived CXCR3 antagonists
    摘要:
    A series of six-six and six-five fused heterocyclic CXCR3 antagonists has been synthesized and their activities evaluated in an [I-125]-IP-10 displacement assay and an ITAC mediated in vitro cell migration assay. The pharmacokinetic properties of several top compounds have also been studied. This effort led to the discovery of compounds with increased potency and improved pharmacokinetic properties that could serve as useful tools to study the role of the CXCR3 receptor in vivo. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.11.060
  • 作为产物:
    描述:
    benzyl (4-(4-iodophenyl)-3-oxobutan-2-yl)carbamate2-氨基苯甲醛氢氧化钾 作用下, 以 乙醇 为溶剂, 以47%的产率得到1-(3-(4-iodophenyl)quinolin-2-yl)ethan-1-amine
    参考文献:
    名称:
    Optimization of the heterocyclic core of the quinazolinone-derived CXCR3 antagonists
    摘要:
    A series of six-six and six-five fused heterocyclic CXCR3 antagonists has been synthesized and their activities evaluated in an [I-125]-IP-10 displacement assay and an ITAC mediated in vitro cell migration assay. The pharmacokinetic properties of several top compounds have also been studied. This effort led to the discovery of compounds with increased potency and improved pharmacokinetic properties that could serve as useful tools to study the role of the CXCR3 receptor in vivo. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.11.060
点击查看最新优质反应信息